Abstract
Chemokines are crucial inflammatory mediators needed during an immune response to clear pathogens. However, their excessive release is the main cause of hyperinflammation. In the recent COVID-19 outbreak, chemokines may be the direct cause of acute respiratory disease syndrome, a major complication leading to death in about 40% of severe cases. Several clinical investigations revealed that chemokines are directly involved in the different stages of SARS-CoV-2 infection. Here, we review the role of chemokines and their receptors in COVID-19 pathogenesis to better understand the disease immunopathology which may aid in developing possible therapeutic targets for the infection.
| Original language | English |
|---|---|
| Pages (from-to) | 976-988 |
| Number of pages | 13 |
| Journal | Computational and Structural Biotechnology Journal |
| Volume | 19 |
| DOIs | |
| State | Published - Jan 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- ARDS
- COVID-19
- Chemokine Receptors
- Chemokines
- Immunity
- SARS-CoV-2
Fingerprint
Dive into the research topics of 'Chemokines and chemokine receptors during COVID-19 infection'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver